Results 161 to 170 of about 1,586 (212)
Autologous peritoneo-fascial patch for portal vein and inferior vena cava reconstruction: a case report with video vignette [PDF]
Journal of Surgical Case ReportsRui Ferreira-Santos, Nuno Gonc̗Alves
exaly +2 more sources
Peritoneo-venous shunt implantation as a therapy for chylous ascites
Phlébologie, 2010 SummaryWe report a case of primary chylous ascites in a progressively poor condition with proteinlosing enteropathy, pleural and pericardiac effusion. Therapy: Denver peritoneo- venous shunt was implanted.
P. Bihari, I. Bihari, G. Tasnádi
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Indications for peritoneo‐jugular shunt for ascites
World Journal of Surgery, 1978AbstractIn the past, refractory ascites was considered to be the only indication for insertion of an ascites valve with a peritoneo‐jugular shunt. Such patients required a prolonged hospital stay prior to surgery and often succumbed to acute renal failure.
H H, LeVeen +3 more
openaire +2 more sources
Peritoneo-cystic shunt for malignant ascites
Gynecologic Oncology, 1984Peritoneo-venous shunting has been used extensively in the treatment of benign ascites and, to a limited extent, in the palliative management of malignant ascites. Acceptance of this therapy for malignant ascites has been slow because of concern over intravascular dissemination of disease.
F B, Stehman, C E, Ehrlich
openaire +2 more sources
Repair of the Inferior Vena Cava With Autogenous Peritoneo-Fascial Patch Graft Following Abdominal Trauma: A Case Report [PDF]
Vascular and Endovascular Surgery, 2008 Abdominal vascular injuries are among the most challenging and lethal injuries in traumatized patients. Inferior vena cava is the most frequently injured vein during the blunt or penetrating trauma.
Yilmaz, Sezgin +7 more
exaly +2 more sources
PERITONEO‐VENOUS SHUNTS FOR MALIGNANT ASCITES
Australian and New Zealand Journal of Surgery, 1982Ten patients with uncontrollable malignant ascites had a Le Veen perltoneo‐venous shunt inserted. A shunt controlled ascites (for up to 15 months) In five of seven patients until death occurred from the underlying malignancy. In two of three surviving patients, a shunt has controlled ascites for six and seven months respectively; in the third patient a
openaire +5 more sources
Radionuclide Assessment of Peritoneo-venous Shunt Patency
Clinical Nuclear Medicine, 1979LeVeen shunt patency can be easily assessed by sequential scintigraphy with a gamma camera after an intraperitoneal injection of Tc-99m-macroaggregated albumin (Tc-99m-MAA). If the shunt is patent, the particles of MAA reach the pulmonary capillary bed and the lungs are visualized.
A, Singh +3 more
openaire +2 more sources